Press Releases
Friends of Cancer Research Announces Election of City of Hope’s Dr. Edward S. Kim to Board of Directors
Friends of Cancer Research (Friends) is excited to announce the addition of City of Hope physician executive Edward S. Kim, M.D., M.B.A., FACP, FASCO, to
New Friends of Cancer Research Manuscript Furthers Work in Aligning Disparate Real-World Data in Oncology
A new manuscript by Friends of Cancer Research (Friends) published today in JCO Clinical Cancer Informatics, details a framework to align electronic patient reported outcome
Statement by Friends of Cancer Research on the VALID Act of 2022
Friends of Cancer Research (Friends) is pleased to support the most recent version of the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) and urges
Friends’ HRD Harmonization Project Announces In Silico Data Readout
Friends of Cancer Research (Friends) is excited to announce new data from the Homologous Recombination Deficiency (HRD) Harmonization Project shared this weekend at The Association
New Manuscript Shows Changes in ctDNA Reflect Clinical Benefit to Patients
A new manuscript by Friends of Cancer Research (Friends) published in JCO Precision Oncology, finds strong associations between reductions in circulating tumor DNA (ctDNA) levels
Statement From Friends of Cancer Research on Monica Bertagnolli’s Nomination as Director of The National Cancer Institute
Friends of Cancer Research (Friends) commends President Joe Biden on nominating Dr. Monica Bertagnolli as the Director of The National Cancer Institute (NCI). As the
Statement on the VALID Act of 2022
Friends of Cancer Research (Friends) applauds the thoughtful work in constructing the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2022 – and particularly for including
New Research Shows Breakthrough Therapy Designated Drugs Provide Maximum Benefit to Patients
A new analysis conducted by Friends of Cancer Research (Friends) published today in Clinical Cancer Research, a journal of the American Association for Cancer Research,
Friends of Cancer Research Statement on the Proposed House and Senate FDA User Fee Legislation
Friends of Cancer Research (Friends) is encouraged by the notable progress being made within the House and Senate on the upcoming reauthorization of the FDA
Dr. Ned Sharpless Stepping Down as National Cancer Institute Director
Friends of Cancer Research (Friends) would like to thank Dr. Ned Sharpless for his tireless public service and scientific leadership as Director of the National